Use of CAR T-cell for acute lymphoblastic leukemia (ALL) treatment: a review study

Acute lymphoblastic leukemia (ALL) is a cancer-specific lymphoid cell. Induction and consolidation chemotherapy alone or in combination with different therapeutic approaches remain the main treatment. Although complete or partial remission of the disease can be achieved, the risk of relapse or refra...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheykhhasan, Mohsen, Manoochehri, Hamed, Dama, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395272/
https://www.ncbi.nlm.nih.gov/pubmed/34987176
http://dx.doi.org/10.1038/s41417-021-00418-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395272/
https://www.ncbi.nlm.nih.gov/pubmed/34987176
http://dx.doi.org/10.1038/s41417-021-00418-1

Ejemplares similares